
Abirakast 250mg Tablet
Marketer
Aprazer Healthcare Pvt Ltd
Salt Composition
Abiraterone Acetate (250mg)
Overview Abirakast 250mg Tablet
Provenge 250mg tablets are indicated for prostate cancer treatment. Additional uses may be determined by your physician. It's often part of a combined chemotherapy regimen. Administering this medication with food is recommended to avoid potential adverse effects. Dosage and frequency are determined individually by your doctor, varying based on your condition and potentially adjusting over time. Strict adherence to your doctor's instructions is crucial; incorrect usage or overdosing can lead to severe complications. Therapeutic benefits may not be apparent immediately; continue treatment unless otherwise directed by your physician. Common side effects include nausea, hypokalemia, edema, leukopenia, and tiredness. Report any concerning or persistent symptoms to your doctor; management strategies are often available. Less frequent but serious side effects signaling liver issues include jaundice, anorexia, dyspnea, dark urine, and nausea. Your doctor may monitor liver function, blood pressure, and potassium levels. Prior to commencing treatment, disclose any pre-existing conditions such as hypertension, cardiac issues, hepatic or renal impairment, or any concurrent medications, particularly those for infections. Significant drug interactions are possible; inform your doctor of all medications you are taking. This medication is contraindicated during pregnancy and breastfeeding due to potential harm to the fetus. Effective contraception for both partners is vital during treatment. Regular blood glucose monitoring might be necessary during therapy.
Uses of Abirakast 250mg Tablet
Malignancy of the prostate gland
Major Benefits of Abirakast 250mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The 250mg Abirakast tablet should be taken on an empty stomach.
Common Side effects of Abirakast 250mg Tablet:
- Edema (swelling)
- Vomiting
- Decreased potassium level in blood
- Fatigue
- Anemia (low number of red blood cells)
- Urinary tract infection
- Diarrhea
- High blood pressure
- Cough
- Joint swelling
How to use Abirakast 250mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 250mg Abirakast tablet whole; do not chew, crush, or divide it. Administer this medication on an empty stomach.
How Abirakast 250mg Tablet works:
Abirakast 250mg tablets are used in cancer treatment. Their mechanism involves suppressing androgen synthesis in males. This effect is achieved through the inhibition of CYP17, a key enzyme in androgen production, thus hindering prostate cancer progression.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction of alcohol and Abirakast 250mg Tablet is undetermined. Seek medical advice before combining them.
PregnancyUNSAFE
Use of Abirakast 250mg tablets is strongly contraindicated in pregnancy. Pregnant women should consult their physician; research in both animals and pregnant humans reveals substantial risks to fetal development.
Breast feedingUNSAFE
The use of Abirakast 250mg tablets while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingSAFE
Driving ability is typically unaffected by taking a 250mg Abirakast tablet.
KidneyCAUTION
For individuals with severely impaired kidney function, Abirakast 250mg Tablets require careful administration. Dosage modification of Abirakast 250mg Tablets might be necessary. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Abirakast 250mg tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Abirakast 250mg Tablet :
Omit any missed Abirakast 250mg Tablet dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Abirakast 250mg Tablet
| Label | Value |
|---|---|
| Type of Compound | Androgen-derived steroid |
| Potential for Dependence | None. |
| Medication Classification | Cancer-fighting drugs |
